AI system for early glaucoma screening
Part of Eyes & vision clinical trials.
This trial tests an artificial intelligence tool that may help detect glaucoma earlier. It compares AI analysis of eye images between people with glaucoma and healthy volunteers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 18 years or older
- Willing to have your eyes examined and images taken
- Either have glaucoma (any type) and are on medication, or have healthy eyes without eye disease
- No eye surgery in the past 3 months
- No other eye diseases that could affect the results
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses an artificial intelligence (AI) program to screen for glaucoma in people who have a family history of the disease. It aims to catch glaucoma early, when it can be treated more effectively.
This trial uses an AI tool to screen for glaucoma at community health centers. If you qualify, you will get a free eye check to catch glaucoma early and help researchers improve screening for high-risk groups.
This trial tests whether artificial intelligence can help find glaucoma early in people with diabetes who already get regular eye checks for diabetic eye disease. It may help catch glaucoma sooner without extra tests.
This study is testing an artificial intelligence tool that can automatically detect signs of glaucoma in photos of the retina. It may help confirm that the AI can accurately identify glaucoma, which could lead to faster diagnosis and monitoring for patients.
This trial uses artificial intelligence to analyze eye images and help doctors diagnose eye diseases. It looks at images from routine care to train and test the AI system.
This study uses an AI-based system to check for diabetic retinopathy during regular eye exams at primary care clinics. It may help catch vision problems early if you have diabetes.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.